SIRT1 and lung cancer: However, compared to SIRT1 KR complementation, SIRT1 WT complementation in SIRT1 KO cells markedly attenuated the doxorubicin-mediated inhibition of clonogenic growth, suggesting that SIRT1 ISGylation is required for lung cancer cell proliferation and survival.